谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase II Trial of Mini-Hyper-cvd-inotuzumab (ino) Followed by Blinatumomab (blina) Consolidation in Patients with Relapsed/refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Cedric Christophe Nasnas,Elias Jabbour,Fadi Haddad,Nicholas James Short,Walid Macaron,Marianne Zoghbi,Lewis Fady Nasr,Nitin Jain,Emmanuel Almanza,Koji Sasaki,Farhad Ravandi,Partow Kebriaei,Xuelin Huang,Guillermo Garcia-Manero,Tapan M. Kadia,Sa A. Wang,Jovitta Jacob,Rebecca Garris,Susan M. O'Brien,Hagop M. Kantarjian

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览27
暂无评分
关键词
Minimal Residual Disease
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要